Drug Discovery Today logo Elsevier logo

Publisher: Elsevier

Related content
Volume 1, Number 2, February 1996

all issues | next issue >

Modified transcriptional activators as therapeutic tools
pp. 50+52-50+52(1)
Author: White J.H.

Automated lead discovery
pp. 46-46(1)
Author: Wallace R.W.

Combinatorial biology
pp. 48-49(2)
Author: Wallace R.W.

New Alzheimer's model from Japan
pp. 49-49(1)
Author: Jack D.B.

Better use aspirin
pp. 49-50(2)
Author: Bradley D.

People
pp. 52-52(1)
Author: Jack D.B.

CAS record
pp. 52-52(1)
Author: Hughes D.

New approach to drug therapy in Alzheimer's dementia
pp. 53-59(7)
Authors: Maelicke A.; Albuquerque E.X.

Squalene synthase inhibitors
pp. 82-82(1)
Authors: Brown G.R.; Harris G.H.

Acyl-CoA:cholesterol acyltransferase inhibitors
pp. 82-82(1)
Author: Roth B.D.

Dopamine D3-antagonists and partial agonists
pp. 82-82(1)
Author: Wright J.

2,4-Diaminopyrrolo-[2,3-d]pyrimidines
pp. 83-83(1)
Author: Bundy G.L.

Selective 5-HT4 receptor antagonists
pp. 83-83(1)
Author: Buchheit K.-H.

alpha-Alkylated gamma,delta-unsaturated amino acids
pp. 83-83(1)
Authors: Kazmaier U.; Maire S.

N-Acetyl-alpha-d mannosamine 1-phosphate analogues
pp. 83-83(1)
Author: Cipolla L.

Synthesis of pyrrolo [2,3-d]pyrimidines
pp. 83-84(2)
Authors: Taylor E.C.; Patel H.H.; Jun J.G.

Chiral boron enolates
pp. 84-84(1)
Authors: Gennari C.; Pain G.; Moresca D.

Synthesis of l-(+)-ergothioneine
pp. 84-84(1)
Authors: Xu J.; Yadan J.C.

all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page